Former MiMedX Execs Convicted On Securities Fraud Charges

The fraud caused the company’s annual revenue for 2015 to be inflated by about $8.2m

The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.

Close convicted man with handcuffs behind grids - Image

Two former top execs at publicly traded wound care company MiMedx Group Inc. have been convicted on securities fraud charges in a New York court, the US Department of Justice announced recently.

A jury in the Southern District of New York convicted former MiMedX CEO Parker “Pete” Petit of securities fraud, while former COO William Taylor was convicted of conspiracy to commit...

More from Compliance

More from Policy & Regulation